{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:05:23Z","timestamp":1786982723992,"version":"build-2736575974"},"reference-count":146,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infect Dis Ther"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s40121-022-00713-w","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T07:03:01Z","timestamp":1668495781000},"page":"33-51","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Plasmodium vivax in Children: Hidden Burden and Conspicuous Challenges, a Narrative Review"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8994-2816","authenticated-orcid":false,"given":"Myriam","family":"Drysdale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3822-497X","authenticated-orcid":false,"given":"Lionel","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2184-562X","authenticated-orcid":false,"given":"Isabelle Borghini","family":"Fuhrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9649-4847","authenticated-orcid":false,"given":"Stephan","family":"Duparc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6396-2344","authenticated-orcid":false,"given":"Hema","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"10195","key":"713_CR1","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/s0140-6736(19)31096-7","volume":"394","author":"KE Battle","year":"2019","unstructured":"Battle KE, Lucas TCD, Nguyen M, et\u00a0al. Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000\u201317: a spatial and temporal modelling study. Lancet (London). 2019;394(10195):332\u201343. https:\/\/doi.org\/10.1016\/s0140-6736(19)31096-7.","journal-title":"Lancet (London)"},{"issue":"1","key":"713_CR2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4269\/ajtmh.12-0610","volume":"91","author":"AM Quispe","year":"2014","unstructured":"Quispe AM, Pozo E, Guerrero E, et\u00a0al. Plasmodium vivax hospitalizations in a monoendemic malaria region: severe vivax malaria? Am J Trop Med Hyg. 2014;91(1):11\u20137. https:\/\/doi.org\/10.4269\/ajtmh.12-0610.","journal-title":"Am J Trop Med Hyg"},{"key":"713_CR3","volume-title":"20 years of global progress and challenges","author":"World malaria report","year":"2020","unstructured":"World malaria report. 20 years of global progress and challenges. Geneva: World Health Organization; 2020."},{"issue":"9","key":"713_CR4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001814","volume":"6","author":"PW Gething","year":"2012","unstructured":"Gething PW, Elyazar IR, Moyes CL, et\u00a0al. A long neglected world malaria map: Plasmodium vivax endemicity in 2010. PLoS Negl Trop Dis. 2012;6(9): e1814. https:\/\/doi.org\/10.1371\/journal.pntd.0001814.","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"713_CR5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/s2352-4642(20)30127-9","volume":"4","author":"EA Ashley","year":"2020","unstructured":"Ashley EA, Poespoprodjo JR. Treatment and prevention of malaria in children. Lancet Child Adolesc Health. 2020;4(10):775\u201389. https:\/\/doi.org\/10.1016\/s2352-4642(20)30127-9.","journal-title":"Lancet Child Adolesc Health"},{"issue":"6 Suppl","key":"713_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.4269\/ajtmh.16-0141","volume":"95","author":"RE Howes","year":"2016","unstructured":"Howes RE, Battle KE, Mendis KN, et\u00a0al. Global epidemiology of Plasmodium vivax. Am J Trop Med Hyg. 2016;95(6 Suppl):15\u201334. https:\/\/doi.org\/10.4269\/ajtmh.16-0141.","journal-title":"Am J Trop Med Hyg"},{"issue":"1\u20132 Suppl","key":"713_CR7","doi-asserted-by":"publisher","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","volume":"64","author":"K Mendis","year":"2001","unstructured":"Mendis K, Sina BJ, Marchesini P, Carter R. The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg. 2001;64(1\u20132 Suppl):97\u2013106. https:\/\/doi.org\/10.4269\/ajtmh.2001.64.97.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"713_CR8","doi-asserted-by":"publisher","first-page":"997","DOI":"10.4269\/ajtmh.2007.76.997","volume":"76","author":"P Michon","year":"2007","unstructured":"Michon P, Cole-Tobian JL, Dabod E, et\u00a0al. The risk of malarial infections and disease in Papua New Guinean children. Am J Trop Med Hyg. 2007;76(6):997\u20131008.","journal-title":"Am J Trop Med Hyg"},{"issue":"6 Suppl","key":"713_CR9","doi-asserted-by":"publisher","first-page":"79","DOI":"10.4269\/ajtmh.2007.77.79","volume":"77","author":"RN Price","year":"2007","unstructured":"Price RN, Tjitra E, Guerra CA, Yeung S, White NJ, Anstey NM. Vivax malaria: neglected and not benign. Am J Trop Med Hyg. 2007;77(6 Suppl):79\u201387.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"713_CR10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/tropej\/fmm074","volume":"54","author":"AJ Rodriguez-Morales","year":"2008","unstructured":"Rodriguez-Morales AJ, Ben\u00edtez JA, Arria M. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J Trop Pediatr. 2008;54(2):94\u2013101. https:\/\/doi.org\/10.1093\/tropej\/fmm074.","journal-title":"J Trop Pediatr"},{"issue":"1","key":"713_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12916-019-1456-9","volume":"17","author":"M Ome-Kaius","year":"2019","unstructured":"Ome-Kaius M, Kattenberg JH, Zaloumis S, et\u00a0al. Differential impact of malaria control interventions on P falciparum and P vivax infections in young Papua New Guinean children. BMC Med. 2019;17(1):220. https:\/\/doi.org\/10.1186\/s12916-019-1456-9.","journal-title":"BMC Med"},{"issue":"1","key":"713_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007140","volume":"13","author":"KA Twohig","year":"2019","unstructured":"Twohig KA, Pfeffer DA, Baird JK, et\u00a0al. Growing evidence of Plasmodium vivax across malaria-endemic Africa. PLoS Negl Trop Dis. 2019;13(1): e0007140. https:\/\/doi.org\/10.1371\/journal.pntd.0007140.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"713_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050127","volume":"5","author":"B Genton","year":"2008","unstructured":"Genton B, D\u2019Acremont V, Rare L, et\u00a0al. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 2008;5(6): e127. https:\/\/doi.org\/10.1371\/journal.pmed.0050127.","journal-title":"PLoS Med"},{"issue":"1","key":"713_CR14","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3201\/eid1101.040519","volume":"11","author":"DK Kochar","year":"2005","unstructured":"Kochar DK, Saxena V, Singh N, Kochar SK, Kumar SV, Das A. Plasmodium vivax malaria. Emerg Infect Dis. 2005;11(1):132\u20134. https:\/\/doi.org\/10.3201\/eid1101.040519.","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"713_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0050128","volume":"5","author":"E Tjitra","year":"2008","unstructured":"Tjitra E, Anstey NM, Sugiarto P, et\u00a0al. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 2008;5(6): e128. https:\/\/doi.org\/10.1371\/journal.pmed.0050128.","journal-title":"PLoS Med"},{"issue":"7","key":"713_CR16","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s12098-017-2332-2","volume":"84","author":"S Basu","year":"2017","unstructured":"Basu S, Sahi PK. Malaria: an update. Indian J Pediatr. 2017;84(7):521\u20138. https:\/\/doi.org\/10.1007\/s12098-017-2332-2.","journal-title":"Indian J Pediatr"},{"issue":"1","key":"713_CR17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12936-019-2644-y","volume":"18","author":"A Daher","year":"2019","unstructured":"Daher A, Silva J, Stevens A, et\u00a0al. Evaluation of Plasmodium vivax malaria recurrence in Brazil. Malar J. 2019;18(1):18. https:\/\/doi.org\/10.1186\/s12936-019-2644-y.","journal-title":"Malar J"},{"issue":"1","key":"713_CR18","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s12936-021-03790-3","volume":"20","author":"T Gari","year":"2021","unstructured":"Gari T, Solomon T, Lindtj\u00f8rn B. Older children are at increased risk of Plasmodium vivax in south-central Ethiopia: a cohort study. Malar J. 2021;20(1):251. https:\/\/doi.org\/10.1186\/s12936-021-03790-3.","journal-title":"Malar J"},{"key":"713_CR19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/1475-2875-6-37","volume":"6","author":"S Incardona","year":"2007","unstructured":"Incardona S, Vong S, Chiv L, et\u00a0al. Large-scale malaria survey in Cambodia: novel insights on species distribution and risk factors. Malar J. 2007;6:37. https:\/\/doi.org\/10.1186\/1475-2875-6-37.","journal-title":"Malar J"},{"issue":"1","key":"713_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12936-017-1925-6","volume":"16","author":"J Recht","year":"2017","unstructured":"Recht J, Siqueira AM, Monteiro WM, Herrera SM, Herrera S, Lacerda MVG. Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination. Malar J. 2017;16(1):273. https:\/\/doi.org\/10.1186\/s12936-017-1925-6.","journal-title":"Malar J"},{"issue":"6","key":"713_CR21","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1016\/s0035-9203(96)90406-x","volume":"90","author":"K Maitland","year":"1996","unstructured":"Maitland K, Williams TN, Bennett S, et\u00a0al. The interaction between Plasmodium falciparum and P.\u00a0vivax in children on Espiritu Santo island, Vanuatu. Trans R Soc Trop Med Hyg. 1996;90(6):614\u201320. https:\/\/doi.org\/10.1016\/s0035-9203(96)90406-x.","journal-title":"Trans R Soc Trop Med Hyg."},{"issue":"3","key":"713_CR22","doi-asserted-by":"publisher","first-page":"452","DOI":"10.4269\/ajtmh.2009.80.452","volume":"80","author":"S Ladeia-Andrade","year":"2009","unstructured":"Ladeia-Andrade S, Ferreira MU, de Carvalho ME, Curado I, Coura JR. Age-dependent acquisition of protective immunity to malaria in riverine populations of the Amazon Basin of Brazil. The Am J Trop Med Hyg. 2009;80(3):452\u20139.","journal-title":"The Am J Trop Med Hyg"},{"issue":"2","key":"713_CR23","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1017\/s0031182015000670","volume":"143","author":"RJ Longley","year":"2016","unstructured":"Longley RJ, Sattabongkot J, Mueller I. Insights into the naturally acquired immune response to Plasmodium vivax malaria. Parasitology. 2016;143(2):154\u201370. https:\/\/doi.org\/10.1017\/s0031182015000670.","journal-title":"Parasitology"},{"issue":"2\u20133","key":"713_CR24","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijpara.2016.06.002","volume":"47","author":"MJ Boyle","year":"2017","unstructured":"Boyle MJ, Reiling L, Osier FH, Fowkes FJ. Recent insights into humoral immunity targeting Plasmodium falciparum and Plasmodium vivax malaria. Int J Parasitol. 2017;47(2\u20133):99\u2013104. https:\/\/doi.org\/10.1016\/j.ijpara.2016.06.002.","journal-title":"Int J Parasitol"},{"issue":"1","key":"713_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/cmi.13110","volume":"22","author":"LJ Chan","year":"2020","unstructured":"Chan LJ, Dietrich MH, Nguitragool W, Tham WH. Plasmodium vivax reticulocyte binding proteins for invasion into reticulocytes. Cell Microbiol. 2020;22(1): e13110. https:\/\/doi.org\/10.1111\/cmi.13110.","journal-title":"Cell Microbiol"},{"issue":"4\u20135","key":"713_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.micinf.2021.104807","volume":"23","author":"KJ Rogers","year":"2021","unstructured":"Rogers KJ, Vijay R, Butler NS. Anti-malarial humoral immunity: the long and short of it. Microbes Infect. 2021;23(4\u20135): 104807. https:\/\/doi.org\/10.1016\/j.micinf.2021.104807.","journal-title":"Microbes Infect"},{"issue":"9","key":"713_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0203673","volume":"13","author":"A Feged-Rivadeneira","year":"2018","unstructured":"Feged-Rivadeneira A, \u00c1ngel A, Gonz\u00e1lez-Casabianca F, Rivera C. Malaria intensity in Colombia by regions and populations. PLoS ONE. 2018;13(9): e0203673. https:\/\/doi.org\/10.1371\/journal.pone.0203673.","journal-title":"PLoS ONE"},{"issue":"4","key":"713_CR28","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1080\/00034983.1995.11812966","volume":"89","author":"B Genton","year":"1995","unstructured":"Genton B, al-Yaman F, Beck HP, et\u00a0al. The epidemiology of malaria in the Wosera area, East Sepik Province, Papua New Guinea, in preparation for vaccine trials I Malariometric indices and immunity. Ann Trop Med Parasitol. 1995;89(4):359\u201376. https:\/\/doi.org\/10.1080\/00034983.1995.11812966.","journal-title":"Ann Trop Med Parasitol."},{"issue":"4","key":"713_CR29","doi-asserted-by":"publisher","first-page":"588","DOI":"10.4269\/ajtmh.2006.75.588","volume":"75","author":"LJ Kasehagen","year":"2006","unstructured":"Kasehagen LJ, Mueller I, McNamara DT, et\u00a0al. Changing patterns of plasmodium blood-stage infections in the Wosera region of Papua New Guinea monitored by light microscopy and high throughput PCR diagnosis. Am J Trop Med Hyg. 2006;75(4):588\u201396.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"713_CR30","doi-asserted-by":"publisher","first-page":"e9047","DOI":"10.1371\/journal.pone.0009047","volume":"5","author":"E Lin","year":"2010","unstructured":"Lin E, Kiniboro B, Gray L, et\u00a0al. Differential patterns of infection and disease with P.\u00a0falciparum and P.\u00a0vivax in young Papua New Guinean children. PLoS ONE. 2010;5(2):e9047. https:\/\/doi.org\/10.1371\/journal.pone.0009047.","journal-title":"PLoS ONE"},{"key":"713_CR31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/1475-2875-7-99","volume":"7","author":"W Phimpraphi","year":"2008","unstructured":"Phimpraphi W, Paul RE, Yimsamran S, et\u00a0al. Longitudinal study of Plasmodium falciparum and Plasmodium vivax in a Karen population in Thailand. Malar J. 2008;7:99. https:\/\/doi.org\/10.1186\/1475-2875-7-99.","journal-title":"Malar J"},{"issue":"2","key":"713_CR32","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/s0035-9203(96)90102-9","volume":"90","author":"C Luxemburger","year":"1996","unstructured":"Luxemburger C, Thwai KL, White NJ, et\u00a0al. The epidemiology of malaria in a Karen population on the western border of Thailand. Trans R Soc Trop Med Hyg. 1996;90(2):105\u201311. https:\/\/doi.org\/10.1016\/s0035-9203(96)90102-9.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"713_CR33","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/imr.12816","volume":"293","author":"LR Antonelli","year":"2020","unstructured":"Antonelli LR, Junqueira C, Vinetz JM, Golenbock DT, Ferreira MU, Gazzinelli RT. The immunology of Plasmodium vivax malaria. Immunol Rev. 2020;293(1):163\u201389. https:\/\/doi.org\/10.1111\/imr.12816.","journal-title":"Immunol Rev"},{"issue":"40","key":"713_CR34","doi-asserted-by":"publisher","first-page":"17327","DOI":"10.1073\/pnas.1008151107","volume":"107","author":"WH Tham","year":"2010","unstructured":"Tham WH, Wilson DW, Lopaticki S, et\u00a0al. Complement receptor 1 is the host erythrocyte receptor for Plasmodium falciparum PfRh4 invasion ligand. Proc Natl Acad Sci U S A. 2010;107(40):17327\u201332. https:\/\/doi.org\/10.1073\/pnas.1008151107.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"713_CR35","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/1475-2875-13-144","volume":"13","author":"KE Battle","year":"2014","unstructured":"Battle KE, Karhunen MS, Bhatt S, et\u00a0al. Geographical variation in Plasmodium vivax relapse. Malar J. 2014;13:144. https:\/\/doi.org\/10.1186\/1475-2875-13-144.","journal-title":"Malar J"},{"issue":"6","key":"713_CR36","doi-asserted-by":"publisher","first-page":"121","DOI":"10.4269\/ajtmh.16-0093","volume":"95","author":"C Surjadjaja","year":"2016","unstructured":"Surjadjaja C, Surya A, Baird JK. Epidemiology of Plasmodium vivax in Indonesia. Am J Trop Med Hyg. 2016;95(6):121\u201332. https:\/\/doi.org\/10.4269\/ajtmh.16-0093.","journal-title":"Am J Trop Med Hyg."},{"key":"713_CR37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1475-2875-7-148","volume":"7","author":"M Karyana","year":"2008","unstructured":"Karyana M, Burdarm L, Yeung S, et\u00a0al. Malaria morbidity in Papua Indonesia, an area with multidrug resistant Plasmodium vivax and Plasmodium falciparum. Malar J. 2008;7:148. https:\/\/doi.org\/10.1186\/1475-2875-7-148.","journal-title":"Malar J"},{"issue":"9","key":"713_CR38","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1086\/586743","volume":"46","author":"JR Poespoprodjo","year":"2008","unstructured":"Poespoprodjo JR, Fobia W, Kenangalem E, et\u00a0al. Adverse pregnancy outcomes in an area where multidrug-resistant Plasmodium vivax and Plasmodium falciparum infections are endemic. Clin Infect Dis. 2008;46(9):1374\u201381. https:\/\/doi.org\/10.1086\/586743.","journal-title":"Clin Infect Dis"},{"issue":"9","key":"713_CR39","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/s1473-3099(09)70177-x","volume":"9","author":"I Mueller","year":"2009","unstructured":"Mueller I, Galinski MR, Baird JK, et\u00a0al. Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite. Lancet Infect Dis. 2009;9(9):555\u201366. https:\/\/doi.org\/10.1016\/s1473-3099(09)70177-x.","journal-title":"Lancet Infect Dis"},{"issue":"1","key":"713_CR40","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1128\/iai.00931-13","volume":"82","author":"A Kaneko","year":"2014","unstructured":"Kaneko A, Chaves LF, Taleo G, et\u00a0al. Characteristic age distribution of Plasmodium vivax infections after malaria elimination on Aneityum Island, Vanuatu. Infect Immun. 2014;82(1):243\u201352. https:\/\/doi.org\/10.1128\/iai.00931-13.","journal-title":"Infect Immun"},{"issue":"1","key":"713_CR41","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1186\/s12936-017-2031-5","volume":"16","author":"A Nissen","year":"2017","unstructured":"Nissen A, Cook J, Loha E, Lindtj\u00f8rn B. Proximity to vector breeding site and risk of Plasmodium vivax infection: a prospective cohort study in rural Ethiopia. Malar J. 2017;16(1):380. https:\/\/doi.org\/10.1186\/s12936-017-2031-5.","journal-title":"Malar J"},{"issue":"1","key":"713_CR42","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4269\/ajtmh.2009.80.103","volume":"80","author":"I Peterson","year":"2009","unstructured":"Peterson I, Borrell LN, El-Sadr W, Teklehaimanot A. Individual and household level factors associated with malaria incidence in a highland region of Ethiopia: a multilevel analysis. Am J Trop Med Hyg. 2009;80(1):103\u201311.","journal-title":"Am J Trop Med Hyg"},{"issue":"7281","key":"713_CR43","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1136\/bmj.322.7281.270","volume":"322","author":"S Abdulla","year":"2001","unstructured":"Abdulla S, Schellenberg JA, Nathan R, et\u00a0al. Impact on malaria morbidity of a programme supplying insecticide treated nets in children aged under 2 years in Tanzania: community cross sectional study. BMJ. 2001;322(7281):270\u20133. https:\/\/doi.org\/10.1136\/bmj.322.7281.270.","journal-title":"BMJ"},{"issue":"2 Suppl","key":"713_CR44","doi-asserted-by":"publisher","first-page":"174","DOI":"10.4269\/ajtmh.2004.71.174","volume":"71","author":"LM Barat","year":"2004","unstructured":"Barat LM, Palmer N, Basu S, Worrall E, Hanson K, Mills A. Do malaria control interventions reach the poor? A view through the equity lens. Am J Trop Med Hyg. 2004;71(2 Suppl):174\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"713_CR45","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1093\/heapol\/czi043","volume":"20","author":"D Filmer","year":"2005","unstructured":"Filmer D. Fever and its treatment among the more and less poor in sub-Saharan Africa. Health Policy Plan. 2005;20(6):337\u201346. https:\/\/doi.org\/10.1093\/heapol\/czi043.","journal-title":"Health Policy Plan"},{"key":"713_CR46","doi-asserted-by":"publisher","first-page":"754","DOI":"10.7897\/2277-4343.04526","volume":"4","author":"K Ravindra","year":"2013","unstructured":"Ravindra K, Shinde R, Mayur G, et\u00a0al. Epidemiological review of malaria with reference to causality analysis, treatment monitoring and outcome. Int J Ayurveda Res. 2013;4:754\u20138. https:\/\/doi.org\/10.7897\/2277-4343.04526.","journal-title":"Int J Ayurveda Res"},{"issue":"1","key":"713_CR47","doi-asserted-by":"publisher","first-page":"33","DOI":"10.5751\/ES-06134-190133","volume":"19","author":"JG Siri","year":"2014","unstructured":"Siri JG. Independent associations of maternal education and household wealth with malaria risk in children. Ecol Soc. 2014;19(1):33. https:\/\/doi.org\/10.5751\/ES-06134-190133.","journal-title":"Ecol Soc"},{"issue":"3","key":"713_CR48","doi-asserted-by":"publisher","first-page":"391","DOI":"10.4269\/ajtmh.2010.09-0047","volume":"82","author":"JG Siri","year":"2010","unstructured":"Siri JG, Wilson ML, Murray S, et\u00a0al. Significance of travel to rural areas as a risk factor for malarial anemia in an urban setting. Am J Trop Med Hyg. 2010;82(3):391\u20137. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0047.","journal-title":"Am J Trop Med Hyg"},{"issue":"6872","key":"713_CR49","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1038\/415680a","volume":"415","author":"J Sachs","year":"2002","unstructured":"Sachs J, Malaney P. The economic and social burden of malaria. Nature. 2002;415(6872):680\u20135. https:\/\/doi.org\/10.1038\/415680a.","journal-title":"Nature"},{"issue":"4","key":"713_CR50","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.pcl.2017.03.004","volume":"64","author":"LM Cohee","year":"2017","unstructured":"Cohee LM, Laufer MK. Malaria in children. Pediatr Clin North Am. 2017;64(4):851\u201366. https:\/\/doi.org\/10.1016\/j.pcl.2017.03.004.","journal-title":"Pediatr Clin North Am"},{"issue":"3","key":"713_CR51","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.siny.2007.01.018","volume":"12","author":"C Menendez","year":"2007","unstructured":"Menendez C, Mayor A. Congenital malaria: the least known consequence of malaria in pregnancy. Semin Fetal Neonatal Med. 2007;12(3):207\u201313. https:\/\/doi.org\/10.1016\/j.siny.2007.01.018.","journal-title":"Semin Fetal Neonatal Med"},{"key":"713_CR52","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/b978-0-12-397900-1.00003-7","volume":"80","author":"NM Anstey","year":"2012","unstructured":"Anstey NM, Douglas NM, Poespoprodjo JR, Price RN. Plasmodium vivax: clinical spectrum, risk factors and pathogenesis. Adv Parasitol. 2012;80:151\u2013201. https:\/\/doi.org\/10.1016\/b978-0-12-397900-1.00003-7.","journal-title":"Adv Parasitol"},{"issue":"1","key":"713_CR53","doi-asserted-by":"publisher","DOI":"10.4084\/mjhid.2012.026","volume":"4","author":"A Bartoloni","year":"2012","unstructured":"Bartoloni A, Zammarchi L. Clinical aspects of uncomplicated and severe malaria. Mediterr J Hematol Infect Dis. 2012;4(1): e2012026. https:\/\/doi.org\/10.4084\/mjhid.2012.026.","journal-title":"Mediterr J Hematol Infect Dis"},{"issue":"10130","key":"713_CR54","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/s0140-6736(18)30324-6","volume":"391","author":"EA Ashley","year":"2018","unstructured":"Ashley EA, Pyae Phyo A, Woodrow CJ. Malaria. Lancet. 2018;391(10130):1608\u201321. https:\/\/doi.org\/10.1016\/s0140-6736(18)30324-6.","journal-title":"Lancet"},{"issue":"9","key":"713_CR55","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1086\/339885","volume":"185","author":"NM Anstey","year":"2002","unstructured":"Anstey NM, Jacups SP, Cain T, et\u00a0al. Pulmonary manifestations of uncomplicated falciparum and vivax malaria: cough, small airways obstruction, impaired gas transfer, and increased pulmonary phagocytic activity. J Infect Dis. 2002;185(9):1326\u201334. https:\/\/doi.org\/10.1086\/339885.","journal-title":"J Infect Dis"},{"key":"713_CR56","unstructured":"Guidelines for the Treatment of Malaria. Geneva: World Health Organization; 2015. 313 p."},{"issue":"7","key":"713_CR57","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1046\/j.1365-3156.2001.00739.x","volume":"6","author":"D Chandramohan","year":"2001","unstructured":"Chandramohan D, Carneiro I, Kavishwar A, Brugha R, Desai V, Greenwood B. A clinical algorithm for the diagnosis of malaria: results of an evaluation in an area of low endemicity. Trop Med Int Health. 2001;6(7):505\u201310. https:\/\/doi.org\/10.1046\/j.1365-3156.2001.00739.x.","journal-title":"Trop Med Int Health"},{"issue":"1","key":"713_CR58","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1590\/s0036-46652003000100006","volume":"45","author":"M Echeverri","year":"2003","unstructured":"Echeverri M, Tob\u00f3n A, Alvarez G, Carmona J, Blair S. Clinical and laboratory findings of Plasmodium vivax malaria in Colombia, 2001. Rev Inst Med Trop Sao Paulo. 2003;45(1):29\u201334. https:\/\/doi.org\/10.1590\/s0036-46652003000100006.","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"1","key":"713_CR59","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/s0035-9203(98)90950-6","volume":"92","author":"C Luxemburger","year":"1998","unstructured":"Luxemburger C, Nosten F, Kyle DE, Kiricharoen L, Chongsuphajaisiddhi T, White NJ. Clinical features cannot predict a diagnosis of malaria or differentiate the infecting species in children living in an area of low transmission. Trans R Soc Trop Med Hyg. 1998;92(1):45\u20139. https:\/\/doi.org\/10.1016\/s0035-9203(98)90950-6.","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"1","key":"713_CR60","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s40249-018-0392-9","volume":"7","author":"C Naing","year":"2018","unstructured":"Naing C, Whittaker MA. Severe thrombocytopaenia in patients with vivax malaria compared to falciparum malaria: a systematic review and meta-analysis. Infect Dis Poverty. 2018;7(1):10. https:\/\/doi.org\/10.1186\/s40249-018-0392-9.","journal-title":"Infect Dis Poverty"},{"issue":"4","key":"713_CR61","first-page":"220","volume":"59","author":"A Rasheed","year":"2009","unstructured":"Rasheed A, Saeed S, Khan SA. Clinical and laboratory findings in acute malaria caused by various plasmodium species. J Pak Med Assoc. 2009;59(4):220\u20133.","journal-title":"J Pak Med Assoc"},{"issue":"1","key":"713_CR62","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1186\/s12936-016-1323-5","volume":"15","author":"PE Chaparro-Narv\u00e1ez","year":"2016","unstructured":"Chaparro-Narv\u00e1ez PE, Lopez-Perez M, Rengifo LM, Padilla J, Herrera S, Ar\u00e9valo-Herrera M. Clinical and epidemiological aspects of complicated malaria in Colombia, 2007\u20132013. Malar J. 2016;15(1):269. https:\/\/doi.org\/10.1186\/s12936-016-1323-5.","journal-title":"Malar J"},{"issue":"1","key":"713_CR63","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1186\/s12879-019-4497-y","volume":"19","author":"D Patriani","year":"2019","unstructured":"Patriani D, Arguni E, Kenangalem E, et\u00a0al. Early and late mortality after malaria in young children in Papua, Indonesia. BMC Infect Dis. 2019;19(1):922. https:\/\/doi.org\/10.1186\/s12879-019-4497-y.","journal-title":"BMC Infect Dis"},{"issue":"9918","key":"713_CR64","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/s0140-6736(13)60024-0","volume":"383","author":"NJ White","year":"2014","unstructured":"White NJ, Pukrittayakamee S, Hien TT, Faiz MA, Mokuolu OA, Dondorp AM. Malaria. Lancet. 2014;383(9918):723\u201335. https:\/\/doi.org\/10.1016\/s0140-6736(13)60024-0.","journal-title":"Lancet"},{"issue":"12","key":"713_CR65","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1086\/599041","volume":"48","author":"JR Poespoprodjo","year":"2009","unstructured":"Poespoprodjo JR, Fobia W, Kenangalem E, et\u00a0al. Vivax malaria: a major cause of morbidity in early infancy. Clin Infect Dis. 2009;48(12):1704\u201312. https:\/\/doi.org\/10.1086\/599041.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"713_CR66","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1128\/cmr.00074-12","volume":"26","author":"JK Baird","year":"2013","unstructured":"Baird JK. Evidence and implications of mortality associated with acute Plasmodium vivax malaria. Clin Microbiol Rev. 2013;26(1):36\u201357. https:\/\/doi.org\/10.1128\/cmr.00074-12.","journal-title":"Clin Microbiol Rev"},{"issue":"3","key":"713_CR67","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3109\/09537104.2011.607520","volume":"23","author":"GS Tanwar","year":"2012","unstructured":"Tanwar GS, Khatri PC, Chahar CK, et\u00a0al. Thrombocytopenia in childhood malaria with special reference to P.\u00a0vivax monoinfection: A study from Bikaner (Northwestern India). Platelets. 2012;23(3):211\u20136. https:\/\/doi.org\/10.3109\/09537104.2011.607520.","journal-title":"Platelets"},{"issue":"3","key":"713_CR68","doi-asserted-by":"publisher","first-page":"733","DOI":"10.4269\/ajtmh.17-0131","volume":"97","author":"F Val","year":"2017","unstructured":"Val F, Machado K, Barbosa L, et\u00a0al. Respiratory complications of plasmodium vivax malaria: systematic review and meta-analysis. Am J Trop Med Hyg. 2017;97(3):733\u201343. https:\/\/doi.org\/10.4269\/ajtmh.17-0131.","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"713_CR69","doi-asserted-by":"publisher","first-page":"e1001575","DOI":"10.1371\/journal.pmed.1001575","volume":"10","author":"NM Douglas","year":"2013","unstructured":"Douglas NM, Lampah DA, Kenangalem E, et\u00a0al. Major burden of severe anemia from non-falciparum malaria species in Southern Papua: a hospital-based surveillance study. PLoS Med. 2013;10(12):e1001575. https:\/\/doi.org\/10.1371\/journal.pmed.1001575.","journal-title":"PLoS Med."},{"issue":"9","key":"713_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0185435","volume":"12","author":"M Ar\u00e9valo-Herrera","year":"2017","unstructured":"Ar\u00e9valo-Herrera M, Rengifo L, Lopez-Perez M, Arce-Plata MI, Garc\u00eda J, Herrera S. Complicated malaria in children and adults from three settings of the Colombian Pacific Coast: a prospective study. PLoS ONE. 2017;12(9): e0185435. https:\/\/doi.org\/10.1371\/journal.pone.0185435.","journal-title":"PLoS ONE"},{"issue":"1","key":"713_CR71","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1186\/s12879-016-1780-z","volume":"16","author":"Y Demissie","year":"2016","unstructured":"Demissie Y, Ketema T. Complicated malaria symptoms associated with Plasmodium vivax among patients visiting health facilities in Mendi town, Northwest Ethiopia. BMC Infect Dis. 2016;16(1):436. https:\/\/doi.org\/10.1186\/s12879-016-1780-z.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"713_CR72","doi-asserted-by":"publisher","first-page":"981","DOI":"10.4269\/ajtmh.2010.09-0633","volume":"83","author":"DK Kochar","year":"2010","unstructured":"Kochar DK, Tanwar GS, Khatri PC, et\u00a0al. Clinical features of children hospitalized with Malaria\u2014a study from Bikaner, Northwest India. J Am Trop Med Hyg. 2010;83(5):981\u20139. https:\/\/doi.org\/10.4269\/ajtmh.2010.09-0633.","journal-title":"J Am Trop Med Hyg"},{"key":"713_CR73","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1186\/1471-2458-13-637","volume":"13","author":"T Ketema","year":"2013","unstructured":"Ketema T, Bacha K. Plasmodium vivax associated severe malaria complications among children in some malaria endemic areas of Ethiopia. BMC Public Health. 2013;13:637. https:\/\/doi.org\/10.1186\/1471-2458-13-637.","journal-title":"BMC Public Health"},{"key":"713_CR74","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s12936-016-1373-8","volume":"15","author":"E Kenangalem","year":"2016","unstructured":"Kenangalem E, Karyana M, Burdarm L, et\u00a0al. Plasmodium vivax infection: a major determinant of severe anaemia in infancy. Malar J. 2016;15:321. https:\/\/doi.org\/10.1186\/s12936-016-1373-8.","journal-title":"Malar J"},{"issue":"1","key":"713_CR75","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1186\/s12936-018-2509-9","volume":"17","author":"NJ White","year":"2018","unstructured":"White NJ. Anaemia and malaria. Malar J. 2018;17(1):371. https:\/\/doi.org\/10.1186\/s12936-018-2509-9.","journal-title":"Malar J"},{"issue":"4","key":"713_CR76","doi-asserted-by":"publisher","first-page":"410","DOI":"10.4269\/ajtmh.2003.68.410","volume":"68","author":"WE Collins","year":"2003","unstructured":"Collins WE, Jeffery GM, Roberts JM. A retrospective examination of anemia during infection of humans with Plasmodium vivax. Am J Trop Med Hyg. 2003;68(4):410\u20132.","journal-title":"Am J Trop Med Hyg"},{"key":"713_CR77","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1186\/1475-2875-11-135","volume":"11","author":"NM Douglas","year":"2012","unstructured":"Douglas NM, Anstey NM, Buffet PA, et\u00a0al. The anaemia of Plasmodium vivax malaria. Malar J. 2012;11:135. https:\/\/doi.org\/10.1186\/1475-2875-11-135.","journal-title":"Malar J"},{"key":"713_CR78","doi-asserted-by":"publisher","first-page":"bcr2013008851","DOI":"10.1136\/bcr-2013-008851","volume":"2013","author":"AA Agarwal","year":"2013","unstructured":"Agarwal AA, Sonkar A, Kushwaha J, Gaurav K. Spontaneous splenic rupture presenting as haemoperitoneum: coinfection of Plasmodium vivax and Plasmodium falciparum. BMJ Case Rep. 2013;2013:bcr2013008851. https:\/\/doi.org\/10.1136\/bcr-2013-008851.","journal-title":"BMJ Case Rep"},{"issue":"3","key":"713_CR79","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1708-8305.2007.00112.x","volume":"14","author":"BC Jim\u00e9nez","year":"2007","unstructured":"Jim\u00e9nez BC, Navarro M, Huerga H, L\u00f3pez-V\u00e9lez R. Spontaneous splenic rupture due to Plasmodium vivax in a traveler: case report and review. J Travel Med. 2007;14(3):188\u201391. https:\/\/doi.org\/10.1111\/j.1708-8305.2007.00112.x.","journal-title":"J Travel Med"},{"issue":"12","key":"713_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0001934","volume":"6","author":"A Machado Siqueira","year":"2012","unstructured":"Machado Siqueira A, Lopes Magalh\u00e3es BM, Cardoso Melo G, et\u00a0al. Spleen rupture in a case of untreated Plasmodium vivax infection. PLoS Negl Trop Dis. 2012;6(12): e1934. https:\/\/doi.org\/10.1371\/journal.pntd.0001934.","journal-title":"PLoS Negl Trop Dis"},{"issue":"11","key":"713_CR81","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/infdis\/jis580","volume":"206","author":"I Betuela","year":"2012","unstructured":"Betuela I, Rosanas-Urgell A, Kiniboro B, et\u00a0al. Relapses contribute significantly to the risk of Plasmodium vivax infection and disease in Papua New Guinean children 1\u20135 years of age. J Infect Dis. 2012;206(11):1771\u201380. https:\/\/doi.org\/10.1093\/infdis\/jis580.","journal-title":"J Infect Dis"},{"issue":"7","key":"713_CR82","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1086\/512241","volume":"195","author":"M Imwong","year":"2007","unstructured":"Imwong M, Snounou G, Pukrittayakamee S, et\u00a0al. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. J Infect Dis. 2007;195(7):927\u201333. https:\/\/doi.org\/10.1086\/512241.","journal-title":"J Infect Dis"},{"issue":"5","key":"713_CR83","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002784","volume":"16","author":"TV Pham","year":"2019","unstructured":"Pham TV, Nguyen HV, Aguirre AR, et\u00a0al. Plasmodium vivax morbidity after radical cure: A cohort study in Central Vietnam. PLoS Med. 2019;16(5): e1002784. https:\/\/doi.org\/10.1371\/journal.pmed.1002784.","journal-title":"PLoS Med"},{"issue":"1","key":"713_CR84","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12936-017-1944-3","volume":"16","author":"L Golassa","year":"2017","unstructured":"Golassa L, White MT. Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia. Malar J. 2017;16(1):301. https:\/\/doi.org\/10.1186\/s12936-017-1944-3.","journal-title":"Malar J"},{"issue":"10","key":"713_CR85","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001891","volume":"12","author":"LJ Robinson","year":"2015","unstructured":"Robinson LJ, Wampfler R, Betuela I, et\u00a0al. Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model. PLoS Med. 2015;12(10): e1001891. https:\/\/doi.org\/10.1371\/journal.pmed.1001891.","journal-title":"PLoS Med"},{"key":"713_CR86","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/b978-0-12-397900-1.00002-5","volume":"80","author":"NJ White","year":"2012","unstructured":"White NJ, Imwong M. Relapse. Adv Parasitol. 2012;80:113\u201350. https:\/\/doi.org\/10.1016\/b978-0-12-397900-1.00002-5.","journal-title":"Adv Parasitol"},{"key":"713_CR87","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1186\/1475-2875-10-297","volume":"10","author":"NJ White","year":"2011","unstructured":"White NJ. Determinants of relapse periodicity in Plasmodium vivax malaria. Malar J. 2011;10:297. https:\/\/doi.org\/10.1186\/1475-2875-10-297.","journal-title":"Malar J"},{"issue":"8","key":"713_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002379","volume":"14","author":"NM Douglas","year":"2017","unstructured":"Douglas NM, Poespoprodjo JR, Patriani D, et\u00a0al. Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: a hospital-based cohort study. PLoS Med. 2017;14(8): e1002379. https:\/\/doi.org\/10.1371\/journal.pmed.1002379.","journal-title":"PLoS Med"},{"issue":"3","key":"713_CR89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.pt.2009.12.005","volume":"26","author":"TN Wells","year":"2010","unstructured":"Wells TN, Burrows JN, Baird JK. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Trends Parasitol. 2010;26(3):145\u201351. https:\/\/doi.org\/10.1016\/j.pt.2009.12.005.","journal-title":"Trends Parasitol"},{"issue":"3","key":"713_CR90","doi-asserted-by":"publisher","first-page":"386","DOI":"10.4269\/ajtmh.2006.74.386","volume":"74","author":"D Fernando","year":"2006","unstructured":"Fernando D, de Silva D, Carter R, Mendis KN, Wickremasinghe R. A randomized, double-blind, placebo-controlled, clinical trial of the impact of malaria prevention on the educational attainment of school children. Am J Trop Med Hyg. 2006;74(3):386\u201393.","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"713_CR91","doi-asserted-by":"publisher","first-page":"582","DOI":"10.4269\/ajtmh.2003.69.582","volume":"69","author":"SD Fernando","year":"2003","unstructured":"Fernando SD, Gunawardena DM, Bandara MRSS, et\u00a0al. The impact of repeated malaria attacks on the school performance of children. Am J Trop Med Hyg. 2003;69(6):582\u20138.","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"713_CR92","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/ije\/dyr190","volume":"41","author":"G Lee","year":"2012","unstructured":"Lee G, Yori P, Olortegui MP, et\u00a0al. Comparative effects of vivax malaria, fever and diarrhoea on child growth. Int J Epidemiol. 2012;41(2):531\u20139. https:\/\/doi.org\/10.1093\/ije\/dyr190.","journal-title":"Int J Epidemiol"},{"issue":"8","key":"713_CR93","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1309\/J4ANKCCJ147JB2FR","volume":"34","author":"BS Kakkilaya","year":"2003","unstructured":"Kakkilaya BS. Rapid diagnosis of malaria. Lab Med. 2003;34(8):602\u20138. https:\/\/doi.org\/10.1309\/J4ANKCCJ147JB2FR.","journal-title":"Lab Med"},{"issue":"1","key":"713_CR94","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1186\/s12936-021-03688-0","volume":"20","author":"GC de Melo","year":"2021","unstructured":"de Melo GC, Netto RLA, Mwangi VI, et\u00a0al. Performance of a sensitive haemozoin-based malaria diagnostic test validated for vivax malaria diagnosis in Brazilian Amazon. Malar J. 2021;20(1):146. https:\/\/doi.org\/10.1186\/s12936-021-03688-0.","journal-title":"Malar J"},{"issue":"Suppl 1","key":"713_CR95","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/nature05445","volume":"444","author":"ME Rafael","year":"2006","unstructured":"Rafael ME, Taylor T, Magill A, Lim Y-W, Girosi F, Allan R. Reducing the burden of childhood malaria in Africa: the role of improved diagnostics. Nature. 2006;444(Suppl 1):39\u201348. https:\/\/doi.org\/10.1038\/nature05445.","journal-title":"Nature"},{"key":"713_CR96","unstructured":"Krintafel. Prescribing Information. GlaxoSmithKline; 2018. Accessed April 12, 2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/210795s000lbl.pdf"},{"key":"713_CR97","unstructured":"Primaquine Phosphate. Prescribing Information. Bayer; 2007. Accessed April 12, 2022. Available from: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2008\/008316s017lbl.pdf"},{"issue":"4","key":"713_CR98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.5694\/mja2.50474","volume":"212","author":"RJ Commons","year":"2020","unstructured":"Commons RJ, McCarthy JS, Price RN. Tafenoquine for the radical cure and prevention of malaria: the importance of testing for G6PD deficiency. Med J Aust. 2020;212(4):152-153.e1. https:\/\/doi.org\/10.5694\/mja2.50474.","journal-title":"Med J Aust"},{"key":"713_CR99","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/b978-0-12-407826-0.00004-7","volume":"81","author":"RE Howes","year":"2013","unstructured":"Howes RE, Battle KE, Satyagraha AW, Baird JK, Hay SI. G6PD deficiency: global distribution, genetic variants and primaquine therapy. Adv Parasitol. 2013;81:133\u2013201. https:\/\/doi.org\/10.1016\/b978-0-12-407826-0.00004-7.","journal-title":"Adv Parasitol"},{"issue":"11","key":"713_CR100","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001339","volume":"9","author":"RE Howes","year":"2012","unstructured":"Howes RE, Piel FB, Patil AP, et\u00a0al. G6PD deficiency prevalence and estimates of affected populations in malaria endemic countries: a geostatistical model-based map. PLoS Med. 2012;9(11): e1001339. https:\/\/doi.org\/10.1371\/journal.pmed.1001339.","journal-title":"PLoS Med"},{"key":"713_CR101","volume-title":"Safety of 8-aminoquinoline antimalarial medicines","author":"J Recht","year":"2014","unstructured":"Recht J, Ashley E, White N, Organization WH. Safety of 8-aminoquinoline antimalarial medicines. Geneva: World Health Organization; 2014."},{"issue":"4","key":"713_CR102","doi-asserted-by":"publisher","first-page":"34","DOI":"10.3390\/ijns4040034","volume":"4","author":"A Anderle","year":"2018","unstructured":"Anderle A, Bancone G, Domingo GJ, et\u00a0al. Point-of-care testing for G6PD deficiency: opportunities for screening. Int J Neonatal Screen. 2018;4(4):34. https:\/\/doi.org\/10.3390\/ijns4040034.","journal-title":"Int J Neonatal Screen"},{"issue":"4","key":"713_CR103","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006230","volume":"12","author":"J Recht","year":"2018","unstructured":"Recht J, Ashley EA, White NJ. Use of primaquine and glucose-6-phosphate dehydrogenase deficiency testing: Divergent policies and practices in malaria endemic countries. PLoS Negl Trop Dis. 2018;12(4): e0006230. https:\/\/doi.org\/10.1371\/journal.pntd.0006230.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"713_CR104","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/ajcp\/aqaa040","volume":"154","author":"EC Calvaresi","year":"2020","unstructured":"Calvaresi EC, Genzen JR. Evaluating percentage-based reporting of glucose-6-phosphate dehydrogenase (G6PD) enzymatic activity: assessment of patient eligibility for malaria prevention and treatment with tafenoquine. Am J Clin Pathol. 2020;154(2):248\u201354. https:\/\/doi.org\/10.1093\/ajcp\/aqaa040.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"713_CR105","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1093\/inthealth\/ihy060","volume":"11","author":"GJ Domingo","year":"2019","unstructured":"Domingo GJ, Advani N, Satyagraha AW, et\u00a0al. Addressing the gender-knowledge gap in glucose-6-phosphate dehydrogenase deficiency: challenges and opportunities. Int Health. 2019;11(1):7\u201314. https:\/\/doi.org\/10.1093\/inthealth\/ihy060.","journal-title":"Int Health"},{"issue":"12","key":"713_CR106","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1203\/00006450-198012000-00016","volume":"14","author":"SF Travis","year":"1980","unstructured":"Travis SF, Kumar SP, Paez PC, Delivoria-Papadopoulos M. Red cell metabolic alterations in postnatal life in term infants: glycolytic enzymes and glucose-6-phosphate dehydrogenase. Pediatr Res. 1980;14(12):1349\u201352. https:\/\/doi.org\/10.1203\/00006450-198012000-00016.","journal-title":"Pediatr Res"},{"issue":"1","key":"713_CR107","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12936-018-2248-y","volume":"17","author":"CS Chu","year":"2018","unstructured":"Chu CS, Bancone G, Nosten F, White NJ, Luzzatto L. Primaquine-induced haemolysis in females heterozygous for G6PD deficiency. Malar J. 2018;17(1):101. https:\/\/doi.org\/10.1186\/s12936-018-2248-y.","journal-title":"Malar J"},{"issue":"3","key":"713_CR108","doi-asserted-by":"publisher","first-page":"702","DOI":"10.4269\/ajtmh.16-0779","volume":"97","author":"R Rueangweerayut","year":"2017","unstructured":"Rueangweerayut R, Bancone G, Harrell EJ, et\u00a0al. Hemolytic potential of tafenoquine in female volunteers heterozygous for glucose-6-phosphate dehydrogenase (G6PD) deficiency (G6PD mahidol variant) versus G6PD-normal volunteers. Am J Trop Med Hyg. 2017;97(3):702\u201311. https:\/\/doi.org\/10.4269\/ajtmh.16-0779.","journal-title":"Am J Trop Med Hyg"},{"key":"713_CR109","unstructured":"Path. STANDARD G6PD Test receives regulatory approval by the Australian Therapeutic Goods Administration. Accessed August 22, 2022. Available from: https:\/\/www.path.org\/media-center\/standard-g6pd-test-receives-regulatory-approval-australian-therapeutic-goods-administration\/"},{"key":"713_CR110","unstructured":"Baebies. Baebies Announces Submission of 510(k) to U.S. FDA for Glucose-6-Phosphate Dehydrogenase on FINDER. Accessed August 19, 2022. Available from: https:\/\/baebies.com\/baebies-announces-submission-of-510k-to-u-s-fda-for-glucose-6-phosphate-dehydrogenase-on-finder\/"},{"issue":"1","key":"713_CR111","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s40249-021-00889-2","volume":"10","author":"OKM Djigo","year":"2021","unstructured":"Djigo OKM, OuldKhalef Y, OuldAhmedou Salem MS, et\u00a0al. Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania. Infect Dis Poverty. 2021;10(1):105. https:\/\/doi.org\/10.1186\/s40249-021-00889-2.","journal-title":"Infect Dis Poverty"},{"key":"713_CR112","unstructured":"World Health Organization. WHO Guidelines for malaria [Internet]. WHO Global Malaria Programme [updated Jun 3, 2022, cited Aug 2, 2022]. Accessed August 22, 2022. Available from: https:\/\/apps.who.int\/iris\/rest\/bitstreams\/1427681\/retrieve"},{"issue":"10","key":"713_CR113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002928","volume":"16","author":"RJ Commons","year":"2019","unstructured":"Commons RJ, Simpson JA, Thriemer K, et\u00a0al. The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: a systematic review and individual patient data meta-analysis. PLoS Med. 2019;16(10): e1002928. https:\/\/doi.org\/10.1371\/journal.pmed.1002928.","journal-title":"PLoS Med"},{"issue":"10","key":"713_CR114","doi-asserted-by":"publisher","first-page":"CD008492","DOI":"10.1002\/14651858.CD008492.pub3","volume":"2013","author":"N Gogtay","year":"2013","unstructured":"Gogtay N, Kannan S, Thatte UM, Olliaro PL, Sinclair D. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Cochrane Database Syst Rev. 2013;2013(10):CD008492. https:\/\/doi.org\/10.1002\/14651858.CD008492.pub3.","journal-title":"Cochrane Database Syst Rev"},{"key":"713_CR115","doi-asserted-by":"publisher","DOI":"10.1016\/j.parint.2021.102512","volume":"87","author":"S-A Woon","year":"2022","unstructured":"Woon S-A, Manning L, Moore BR. Antimalarials for children with Plasmodium vivax infection: current status, challenges, and research priorities. Parasitol Int. 2022;87: 102512. https:\/\/doi.org\/10.1016\/j.parint.2021.102512.","journal-title":"Parasitol Int"},{"issue":"12","key":"713_CR116","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001773","volume":"11","author":"M Laman","year":"2014","unstructured":"Laman M, Moore BR, Benjamin JM, et\u00a0al. Artemisinin-naphthoquine versus artemether-lumefantrine for uncomplicated malaria in Papua New Guinean children: an open-label randomized trial. PLoS Med. 2014;11(12): e1001773. https:\/\/doi.org\/10.1371\/journal.pmed.1001773.","journal-title":"PLoS Med"},{"issue":"1","key":"713_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0014501","volume":"6","author":"Y Poravuth","year":"2011","unstructured":"Poravuth Y, Socheat D, Rueangweerayut R, et\u00a0al. Pyronaridine-artesunate versus chloroquine in patients with acute plasmodium vivax malaria: a randomized, double-blind, non-inferiority trial. PLoS ONE. 2011;6(1): e14501. https:\/\/doi.org\/10.1371\/journal.pone.0014501.","journal-title":"PLoS ONE"},{"issue":"1","key":"713_CR118","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12936-021-03700-7","volume":"20","author":"NJ White","year":"2021","unstructured":"White NJ. Anti-malarial drug effects on parasite dynamics in vivax malaria. Malar J. 2021;20(1):161. https:\/\/doi.org\/10.1186\/s12936-021-03700-7.","journal-title":"Malar J"},{"issue":"1","key":"713_CR119","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1186\/s12936-019-3072-8","volume":"18","author":"LWP de Sena","year":"2019","unstructured":"de Sena LWP, Mello AGNC, Ferreira MVD, de Ataide MA, Dias RM, Vieira JLF. Doses of chloroquine in the treatment of malaria by Plasmodium vivax in patients between 2 and 14 years of age from the Brazilian Amazon basin. Malar J. 2019;18(1):439. https:\/\/doi.org\/10.1186\/s12936-019-3072-8.","journal-title":"Malar J"},{"issue":"1\u20134","key":"713_CR120","first-page":"68","volume":"57","author":"I Betuela","year":"2014","unstructured":"Betuela I, Robinson LJ, Hetzel MW, et\u00a0al. Primaquine treatment for Plasmodium vivax\u2013an essential tool for malaria control and elimination in Papua New Guinea. P N G Med J. 2014;57(1\u20134):68\u201374.","journal-title":"P N G Med J"},{"issue":"6","key":"713_CR121","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1111\/bcp.12160","volume":"76","author":"AK Miller","year":"2013","unstructured":"Miller AK, Harrell E, Ye L, et\u00a0al. Pharmacokinetic interactions and safety evaluations of coadministered tafenoquine and chloroquine in healthy subjects. Br J Clin Pharmacol. 2013;76(6):858\u201367. https:\/\/doi.org\/10.1111\/bcp.12160.","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"713_CR122","doi-asserted-by":"publisher","first-page":"e00711","DOI":"10.1128\/aac.00711-18","volume":"62","author":"N Thakkar","year":"2018","unstructured":"Thakkar N, Green JA, Koh GCKW, Duparc S, Tenero D, Goyal N. Population pharmacokinetics of tafenoquine, a novel antimalarial. Antimicrob Agents Chemother. 2018;62(11):e00711-e718. https:\/\/doi.org\/10.1128\/aac.00711-18.","journal-title":"Antimicrob Agents Chemother"},{"key":"713_CR123","unstructured":"Developing Paediatric Primaquine. Welcome to DPP Project Website [Internet]. DPP Project [updated 2021, cited April 12, 2022]. Accessed August 22, 2022. Available from: https:\/\/dpp-project.org"},{"issue":"10202","key":"713_CR124","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/s0140-6736(19)31285-1","volume":"394","author":"WRJ Taylor","year":"2019","unstructured":"Taylor WRJ, Thriemer K, von Seidlein L, et\u00a0al. Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial. Lancet. 2019;394(10202):929\u201338. https:\/\/doi.org\/10.1016\/s0140-6736(19)31285-1.","journal-title":"Lancet"},{"issue":"6","key":"713_CR125","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1016\/j.xphs.2018.02.015","volume":"107","author":"RK Oberoi","year":"2018","unstructured":"Oberoi RK, Zhao W, Sidhu DS, Viani RM, Trinh R, Liu W. A phase 1 study to evaluate the effect of crushing, cutting into half, or grinding of glecaprevir\/pibrentasvir tablets on exposures in healthy subjects. J Pharm Sci. 2018;107(6):1724\u201330. https:\/\/doi.org\/10.1016\/j.xphs.2018.02.015.","journal-title":"J Pharm Sci"},{"issue":"5","key":"713_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002299","volume":"14","author":"T Abreha","year":"2017","unstructured":"Abreha T, Hwang J, Thriemer K, et\u00a0al. Comparison of artemether-lumefantrine and chloroquine with and without primaquine for the treatment of Plasmodium vivax infection in Ethiopia: A randomized controlled trial. PLoS Med. 2017;14(5): e1002299. https:\/\/doi.org\/10.1371\/journal.pmed.1002299.","journal-title":"PLoS Med"},{"issue":"2","key":"713_CR127","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/s2352-4642(21)00328-x","volume":"6","author":"ID V\u00e9lez","year":"2022","unstructured":"V\u00e9lez ID, Hien TT, Green JA, et\u00a0al. Tafenoquine exposure assessment, safety, and relapse prevention efficacy in children with Plasmodium vivax malaria: open-label, single-arm, non-comparative, multicentre, pharmacokinetic bridging, phase 2 trial. Lancet Child Adolesc Health. 2022;6(2):86\u201395. https:\/\/doi.org\/10.1016\/s2352-4642(21)00328-x.","journal-title":"Lancet Child Adolesc Health"},{"key":"713_CR128","unstructured":"Baird JK, Sutanto I, Soebandrio A, et\u00a0al. Evaluation of the efficacy and safety of tafenoquine co-administered dihydroartemisinin\u2013piperaquine for the radical cure (anti-relapse) of Plasmodium vivax malaria in Indonesia\u2014INSPECTOR Study. 2020;103(Suppl 5):426."},{"issue":"7","key":"713_CR129","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1093\/cid\/ciy235","volume":"67","author":"ME Gilder","year":"2018","unstructured":"Gilder ME, Hanpithakphong W, Hoglund RM, et\u00a0al. Primaquine pharmacokinetics in lactating women and breastfed infant exposures. Clin Infect Dis. 2018;67(7):1000\u20137. https:\/\/doi.org\/10.1093\/cid\/ciy235.","journal-title":"Clin Infect Dis"},{"issue":"7","key":"713_CR130","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008526","volume":"14","author":"RM Corder","year":"2020","unstructured":"Corder RM, de Lima ACP, Khoury DS, Docken SS, Davenport MP, Ferreira MU. Quantifying and preventing Plasmodium vivax recurrences in primaquine-untreated pregnant women: An observational and modeling study in Brazil. PLoS Negl Trop Dis. 2020;14(7): e0008526. https:\/\/doi.org\/10.1371\/journal.pntd.0008526.","journal-title":"PLoS Negl Trop Dis"},{"key":"713_CR131","unstructured":"Operational Feasibility of Appropriate Radical Cure of Plasmodium Vivax With Tafenoquine or Primaquine After Quantitative G6PD Testing in Brazil (Trust). Clinicaltrials.gov identifier: NCT05096702. Updated April 8, 2022. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05096702. Accessed 6 Jun 2022."},{"issue":"4","key":"713_CR132","first-page":"720","volume":"32","author":"K Buchachart","year":"2001","unstructured":"Buchachart K, Krudsood S, Singhasivanon P, et\u00a0al. Effect of primaquine standard dose (15 mg\/day for 14 days) in the treatment of vivax malaria patients in Thailand Southeast Asian. J Trop Med Public Health. 2001;32(4):720\u20136.","journal-title":"J Trop Med Public Health"},{"issue":"1","key":"713_CR133","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1186\/s12936-018-2380-8","volume":"17","author":"K Thriemer","year":"2018","unstructured":"Thriemer K, Bobogare A, Ley B, et\u00a0al. Quantifying primaquine effectiveness and improving adherence: a round table discussion of the APMEN Vivax Working Group. Malar J. 2018;17(1):241. https:\/\/doi.org\/10.1186\/s12936-018-2380-8.","journal-title":"Malar J"},{"issue":"14","key":"713_CR134","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1056\/NEJMc1301936","volume":"369","author":"JW Bennett","year":"2013","unstructured":"Bennett JW, Pybus BS, Yadava A, et\u00a0al. Primaquine failure and cytochrome P-450 2D6 in Plasmodium vivax malaria. N Engl J Med. 2013;369(14):1381\u20132. https:\/\/doi.org\/10.1056\/NEJMc1301936.","journal-title":"N Engl J Med"},{"key":"713_CR135","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1475-2875-13-2","volume":"13","author":"SR Marcsisin","year":"2014","unstructured":"Marcsisin SR, Sousa JC, Reichard GA, et\u00a0al. Tafenoquine and NPC-1161B require CYP 2D metabolism for anti-malarial activity: implications for the 8-aminoquinoline class of anti-malarial compounds. Malar J. 2014;13:2. https:\/\/doi.org\/10.1186\/1475-2875-13-2.","journal-title":"Malar J"},{"key":"713_CR136","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1186\/1475-2875-13-418","volume":"13","author":"EA Ashley","year":"2014","unstructured":"Ashley EA, Recht J, White NJ. Primaquine: the risks and the benefits. Malar J. 2014;13:418. https:\/\/doi.org\/10.1186\/1475-2875-13-418.","journal-title":"Malar J"},{"issue":"5","key":"713_CR137","doi-asserted-by":"publisher","first-page":"e02590","DOI":"10.1128\/aac.02590-16","volume":"61","author":"BP Gon\u00e7alves","year":"2017","unstructured":"Gon\u00e7alves BP, Pett H, Tiono AB, et\u00a0al. Age, weight, and CYP2D6 genotype are major determinants of primaquine pharmacokinetics in African children. Antimicrob Agents Chemother. 2017;61(5):e02590-16. https:\/\/doi.org\/10.1128\/aac.02590-16.","journal-title":"Antimicrob Agents Chemother"},{"key":"713_CR138","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12936-016-1145-5","volume":"15","author":"PL St Jean","year":"2016","unstructured":"St Jean PL, Xue Z, Carter N, et\u00a0al. Tafenoquine treatment of Plasmodium vivax malaria: suggestive evidence that CYP2D6 reduced metabolism is not associated with relapse in the Phase 2b DETECTIVE trial. Malar J. 2016;15:97. https:\/\/doi.org\/10.1186\/s12936-016-1145-5.","journal-title":"Malar J"},{"key":"713_CR139","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/1475-2875-9-308","volume":"9","author":"R Takeuchi","year":"2010","unstructured":"Takeuchi R, Lawpoolsri S, Imwong M, et\u00a0al. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Malar J. 2010;9:308. https:\/\/doi.org\/10.1186\/1475-2875-9-308.","journal-title":"Malar J"},{"key":"713_CR140","doi-asserted-by":"crossref","unstructured":"Woon S-A, Moore B, Laman M, et\u00a0al. An ultra-short course, high-dose primaquine regimen to prevent Plasmodium vivax relapses following uncomplicated paediatric malaria due to any Plasmodium species. Oral Presentation presented at: 8th International Conference on Plasmodium vivax Research; April 5\u20138, 2022; virtual. Presentation 80264.","DOI":"10.1016\/j.ijid.2023.03.010"},{"issue":"7","key":"713_CR141","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1097\/fpc.0000000000000407","volume":"30","author":"PL St Jean","year":"2020","unstructured":"St Jean PL, Koh GCKW, Breton JJ, et\u00a0al. Pharmacogenetic assessment of tafenoquine efficacy in patients with Plasmodium vivax malaria. Pharmacogenet Genom. 2020;30(7):161\u20135. https:\/\/doi.org\/10.1097\/fpc.0000000000000407.","journal-title":"Pharmacogenet Genom"},{"issue":"8","key":"713_CR142","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043162","volume":"7","author":"RR Abeyasinghe","year":"2012","unstructured":"Abeyasinghe RR, Galappaththy GN, Smith Gueye C, Kahn JG, Feachem RGA. Malaria control and elimination in Sri Lanka: documenting progress and success factors in a conflict setting. PLoS ONE. 2012;7(8): e43162. https:\/\/doi.org\/10.1371\/journal.pone.0043162.","journal-title":"PLoS ONE"},{"issue":"2","key":"713_CR143","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1008258","volume":"16","author":"J Popovici","year":"2020","unstructured":"Popovici J, Roesch C, Rougeron V. The enigmatic mechanisms by which Plasmodium vivax infects Duffy-negative individuals. PLoS Pathog. 2020;16(2): e1008258. https:\/\/doi.org\/10.1371\/journal.ppat.1008258.","journal-title":"PLoS Pathog"},{"issue":"4","key":"713_CR144","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1603\/0022-2585-40.4.379","volume":"40","author":"MM P\u00f3voa","year":"2003","unstructured":"P\u00f3voa MM, Conn JE, Schlichting CD, et\u00a0al. Malaria vectors, epidemiology, and the re-emergence of Anopheles darlingi in Bel\u00e9m, Par\u00e1, Brazil. J Med Entomol. 2003;40(4):379\u201386. https:\/\/doi.org\/10.1603\/0022-2585-40.4.379.","journal-title":"J Med Entomol"},{"issue":"6","key":"713_CR145","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.pt.2020.03.009","volume":"36","author":"RN Price","year":"2020","unstructured":"Price RN, Commons RJ, Battle KE, Thriemer K, Mendis K. Plasmodium vivax in the Era of the shrinking P.\u00a0falciparum map. Trends Parasitol. 2020;36(6):560\u201370. https:\/\/doi.org\/10.1016\/j.pt.2020.03.009.","journal-title":"Trends Parasitol."},{"issue":"1","key":"713_CR146","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s40249-016-0151-8","volume":"5","author":"RE Cibulskis","year":"2016","unstructured":"Cibulskis RE, Alonso P, Aponte J, et\u00a0al. Malaria: global progress 2000\u20132015 and future challenges. Infect Dis Poverty. 2016;5(1):61. https:\/\/doi.org\/10.1186\/s40249-016-0151-8.","journal-title":"Infect Dis Poverty"}],"container-title":["Infectious Diseases and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00713-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40121-022-00713-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40121-022-00713-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T22:51:46Z","timestamp":1678575106000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40121-022-00713-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":146,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1007\/s40121-022-00713-w","relation":{},"ISSN":["2193-8229","2193-6382"],"issn-type":[{"value":"2193-8229","type":"print"},{"value":"2193-6382","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"29 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}